The ninth Liver Forum was held on July 10, 2019 in Paris, France.
152 people attended Liver Forum 9. Of those, 101 attended in-person, and 51 people registered for the webcast.
Materials:
Presentations:
Session I: NASH Clinical Trials Part I - Deep Dive into Recent Trials
Welcome and Project Updates
Katherine Barradas, Forum for Collaborative Research
Lessons Learned from Trials to Date
Mary Rinella, Northwestern University
Transitioning from Pre- to Post-Accelerated Approval
Vlad Ratziu, Hôpital Pitié Salpêtrière
Session II: NASH Clinical Trials Part II - Future Directions
Future of Trial Design and Endpoints for NASH
Arun Sanyal, Virginia Commonwealth University
Estimands in NASH Clinical Trials
Peter Mesenbrink, Novartis Pharmaceuticals
Session III: European Regulatory Updates and Perspective
Review of EMA Reflection Paper and Stakeholder Meeting
Mark Ainsworth, Danish Medicines Agency
Session IV: Working Group Updates
NASH Cirrhosis
Arun Sanyal, Virginia Commonwealth University
Standard of Care: Comorbidity MGMT
Raluca Pais, Hôpital Pitié Salpêtrière
Standard of Care: Lifestyle MGMT (coming soon)
Sven Francque, Antwerp University Hospital
Pediatric Issues
Joel Lavine, Columbia University
